Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: Findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)

The Lancet

Volumn 382, Issue 9907, 2013, Pages 1795-1806

  Sonnenberg, Pam ^a   Clifton, Soazig ^a,b   Beddows, Simon ^c   Field, Nigel ^a   Soldan, Kate ^d   Tanton, Clare ^a   Mercer, Catherine H ^a   Da Silva, Filomeno Coelho ^c   Alexander, Sarah ^e   Copas, Andrew J ^a   Phelps, Andrew ^b   Erens, Bob ^f   Prah, Philip ^a   Macdowall, Wendy ^g   Wellings, Kaye ^g   Ison, Catherine A ^e   Johnson, Anne M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL CENTRE FOR SOCIAL RESEARCH   (United Kingdom)

^c Virus Reference Department   (United Kingdom)

^d Public Health England   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f Department of Health Services Research and Policy ^*  (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONCURRENT SEXUAL PARTNERSHIP; CONDOM USE; FEMALE; GONORRHEA; HEALTH SURVEY; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION PREVENTION; INFECTION RISK; INTERVENTION STUDY; INTERVIEW; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL HEALTH; UNITED KINGDOM; URINALYSIS; VACCINATION; WART VIRUS;

EID: 84888637253     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61947-9     Document Type: Article

References (50)

1. Nicoll A, Hughes G, Donnelly M, et al. Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect 2001; 77: 242-47.
2. Public Health England. Health Protection Report. June 7, 2013. http://www.hpa.org.uk/hpr/archives/2013/hpr2313.pdf (accessed Nov 5, 2013).
3. Johnson AM, Wadsworth J, Wellings K, Field J. The National Survey of Sexual Attitudes and Lifestyles. Oxford: Blackwell Scientifi c Press, 1994.
4. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001; 358: 1835-42.
5. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001; 358: 1851-54.
6. Johnson AM, Mercer CH, Beddows S, et al. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in women and men in Britain. Sex Transm Infect 2012; 88: 212-17.
7. Australian Department of Health and Ageing. Second national sexually transmissible infections strategy 2010-2013. 2010. http://www.health.gov.au/ internet/main/publishing.nsf/Content/ohp-national-strategies-2010-sti (accessed Nov 5, 2013).
8. Laboratory Centre for Disease Control (Canada). Proceedings of the National STD Consensus Meeting and national goals for the prevention and control of sexually transmitted diseases in Canada. Canada: Division of STD Prevention and Control, Bureau of HIV/AIDS and STD, Laboratory Centre for Disease Control, Health Protection Branch, Health Canada; 1997.
9. Ministry of Health, New Zealand. Sexual and reproductive health strategy: phase one. Oct 2, 2001. http://www.health.govt.nz/publication/sexual-and- reproductive-health-strategy-phase-one (accessed Nov 5, 2013).
10. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59: 1-110.
11. WHO. WHO regional strategy on sexual and reproductive health. November, 2001. http://www.euro.who.int/en/what-we-do/healthtopics/Life-stages/sexual-and- reproductive-health/publications/pre- 2007/who-regional-strategy-on-sexual-and- reproductive-health (accessed Nov 5, 2013).
12. Department of Health, Social Services and Public Safety. Sexual health promotion. Strategy and Action Plan 2008-2013. November, 2008. www.dhsspsni.gov.uk/dhssps-sexual-health-plan-front-cvr.pdf (accessed Nov 5, 2013).
13. Department of Health. The national strategy for sexual health and HIV. London: DoH, 2001.
14. Scottish Executive. Respect and responsibility: strategy and action plan for improving sexual health. January, 2005. http://www.scotland. gov.uk/Publications/2005/01/20603/content (accessed Nov 5, 2013).
15. The National Assembly for Wales. A strategic framework for promoting sexual health in Wales. 2001. http://www.shnwales.org. uk/page.cfm?orgid= 485&pid=28869 (accessed Nov 5, 2013).
16. British HIV Association, British Association of Sexual Health and HIV, British Infection Society. UK national guidelines for HIV testing 2008. September, 2008. http://www.bhiva.org/HIVTesting2008.aspx (accessed Nov 5, 2013).
17. Gray M, Nicholson S. National Survey of Sexual Attitudes and Lifestyles 2010: findings and recommendations from cognitive question testing. April, 2009. http://www.natsal.ac.uk/media/822297/natsal%202010- cognitive%20pilot%20report%20-%20fi nal.pdf (accessed Nov 5, 2013).
18. Erens B, Phelps A, Clifton S, et al. Methodology of the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect 2013; published online Nov 26. http://dx.doi.org/10.1136/sextrans-2013-051359.
19. Erens B, Phelps A, Clifton S, et al. The third National Survey of Sexual Attitudes and Lifestyles (Natsal-3): technical report. 2013. http://natsal.ac.uk/natsal-3/methodology (accessed Nov 26, 2013).
20. Mercer CH, Tanton C, Prah P, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013; published online Nov 26. http://dx.doi.org/10.1016/S0140-6736(13)62035-8.
21. Wisniewski CA, White JA, Michel C-EC, et al. Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men. J Clin Microbiol 2008; 46: 1466-69.
22. Bissett SL, Howell-Jones R, Swift C, et al. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 2011; 83: 1744-51.
23. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens- Part B: biological agents. Lancet Oncol 2009; 10: 321-22.
24. Parry JV, Connell JA, Reinbott P, Garcia AB, Avillez F, Mortimer PP. GACPAT HIV 1 + 2: a simple, inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2. J Med Virol 1995; 45: 10-16.
25. Connell JA, Parry JV, Mortimer PP, et al. Preliminary report: accurate assays for anti-HIV in urine. Lancet 1990; 335: 1366-69.
26. Payne RA, Abel GA. UK indices of multiple deprivation - A way to make comparisons across constituent countries easier. Health Stat Q 2012; 53: 22-37.
27. Department of Health. The Public Health Outcomes Framework for England, 2013-2016 and technical updates. Jan 23, 2012. https://www. gov.uk/government/ publications/healthy-lives-healthy-peopleimproving-outcomes-and-supporting- transparency (accessed Nov 5, 2013).
28. Field N, Tanton C, Mercer CH, et al. Testing for sexually transmitted infections in a population-based sexual health survey: development of an acceptable ethical approach. J Med Ethics 2012; 38: 380-82.
29. Mercer CH, Copas AJ, Sonnenberg P, et al. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. Int J Epidemiol 2009; 38: 206-14.
30. Fenton KA, Mercer CH, Johnson AM, et al. Reported sexually transmitted disease clinic attendance and sexually transmitted infections in Britain: prevalence, risk factors, and proportionate population burden. J Infect Dis 2005; 191 (suppl 1): S127-38.
31. Flowers P, Knussen C, Li J, McDaid L. Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK. HIV Med 2013; 14: 92-98.
32. Lattimore S, Thornton A, Delpech V, Elford J. Changing patterns of sexual risk behavior among London gay men: 1998-2008. Sex Transm Dis 2011; 38: 221-29.
33. Health Protection Agency. HIV in the United Kingdom: 2012 report. November, 2012. www.hpa.org.uk/webc/hpawebfi le/hpaweb-c/1317137200016 (accessed Nov 5, 2013).
34. Public Health England. Public Health England. Genitourinary Medicine Clinic Activity Dataset (GUMCADv2). http://www.hpa. org.uk/GUMCAD (accessed Sept 10, 2013).
35. Sheringham J, Mann S, Simms I, Staff ord M, Hart GJ, Raine R. It matters what you measure: a systematic literature review examining whether young people in poorer socioeconomic circumstances are more at risk of chlamydia. Sex Transm Infect 2013; 89: 175-80.
36. Turner KME, Adams EJ, LaMontagne DS, Emmett L, Baster K, Edmunds WJ. Modelling the eff ectiveness of chlamydia screening in England. Sex Transm Infect 2006; 82: 496-502.
37. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194: 1044-57.
38. Hughes A, Mesher, D, White, J, Soldan K. Coverage of the English National HPV Immunisation Programme (2008-2011) among 12-17 year old females by area-level deprivation score. Eurosurveillance (in press).
39. Mesher, D, Howell-Jones R, Panwar, K, et al. Reduction in HPV infection in young women following introduction of HPV immunisation in England. 28th International Papillomavirus Conference; San Juan, Puerto Rico; Nov 30-Dec 6, 2012. E07-664.
40. Tabrizi SN, Brotherton JML, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206: 1645-51.
41. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013; published online June 19. DOI:10.1093/infdis/jit192.
42. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346: f2032.
43. Department of Health. A framework for sexual health improvement in England. March, 2013. https://www.gov.uk/government/publications/a-framework- for-sexual-health-improvement-inengland (accessed Nov 5, 2013).
44. Welsh Assembly Government. Sexual health and wellbeing action plan for Wales, 2010-2015. 2010.http://wales.gov.uk/topics/health/improvement/index/ sexualhealth/?lang=en (accessed June 13, 2013).
45. Lowndes CM, Fenton KA, for the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Surveillance systems for STIs in the European Union: facing a changing epidemiology. Sex Transm Infect 2004; 80: 264-71.
46. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes. htm (accessed June 4, 2013).
47. University of North Carolina, Carolina Population Center. Add Health. http://www.cpc.unc.edu/projects/addhealth (accessed June 4, 2013).
48. Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J. Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect 2010; 86: 263-70.
49. Craig P, Cooper C, Gunnell D, et al. Using natural experiments to evaluate population health interventions: new Medical Research Council guidance. J Epidemiol Community Health 2012; 66: 1182-86.
50. Phillips AN, Cambiano V, Nakagawa F, et al. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One 2013; 8: e55312.